• Peer-reviewed paper published in leading autism journal Autism Research
• Validates BlinkLab's core technology and novel approach to measuring sensorimotor processing in autism
• Independent peer review provides strong support for future regulatory approval and clinical adoption

BlinkLab Limited (ASX:BB1) has announced the publication of a peer-reviewed scientific paper in Autism Research, one of the most prestigious and widely cited journals in the field of neurodevelopmental disorders such as autism. The paper, titled 'Neurobehavioral Assessment of Sensorimotor Function in Autism Using Smartphone Technology', validates BlinkLab's core technology platform and the objective neurophysiological measures it captures, including facial reflexes, startle responses, eye and eyelid movements, postural stability, as well as vocal and behavioural responses recorded using a standard smartphone in at-home environments. The study reports results from a large, multi-centre cohort of 536 children and demonstrates that BlinkLab's platform can reliably detect distinct sensorimotor profiles associated with autism across multiple domains, using objective, reflex-based measures rather than subjective observation from clinicians alone, which is currently the standard for autism assessment globally. The publication materially strengthens BlinkLab's clinical evidence base and represents an important milestone in the Company's regulatory strategy, including engagement with the U.S. Food and Drug Administration (FDA), where peer-reviewed validation in leading journals is a key component of medical device evaluation and adoption.

BlinkLab is taking a deliberate, step-by-step approach to market entry: from scientific adoption, to autism specialty centres and primary care settings. The publication of this peer-reviewed paper is an important milestone, providing strong scientific validation just prior to the start of the company's FDA regulatory trial.